eXIthera


eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation, preventing thrombosis without an increased risk of bleeding.


Org chart

Neil J. Hayward
CEO, President, & Co-Founder
Collapse
Andy Hu
Head, Corporate & Business Development
Michael Kurz
VP, Translational Medicine & Medical Affairs
Priya Jambhekar
Head, Regulatory Affairs

Board & advisors



Offices